HCPCS Level II & CMS Guidelines
HCPCS January 2026 Update: Includes 160 new codes and 101 deletions. Notable additions include new J-codes for FDA-approved products and M-codes for telehealth-conducted encounters.
CMS Terminology Shift: CMS is beginning to phase out the term “Social Determinants of Health” in favor of “upstream drivers” in certain official descriptors.
NCCI Policy Revisions: As of January 1, 2026, 3D rendering (e.g., 76376) may no longer be reported specifically for mapping sites of multiple biopsies under radiologic guidance.
Checklist for 2026
-
- Update Charge Masters: Ensure all deleted LER and MS codes are replaced to avoid immediate denials.
- Audit Remote Monitoring: Update workflows to capture 10-minute treatment management thresholds.
- Document AI Use: Ensure medical records specify if augmentative AI software was used for cardiology or imaging interpretations.
1. Key Behavioral Health & Telehealth G-Codes
New codes facilitate better integration and monitoring of mental health services:
-
- G0568–G0570: New codes for Psychiatric Collaborative Care Management (CoCM) and Behavioral Health Care Planning.
- G0660–G0668: A new series for TEAM remote evaluation and management (E/M) services, aligning with current outpatient E/M timeframes (e.g., G0660 for 10 minutes, G0664 for 60 minutes).
- G9871: A specific code for online diabetes prevention behavioral counseling (60 minutes).
- M1426, M1431, M1436+: New M-codes specifically to identify encounters conducted via telehealth across various specialties.
2. Medical Supplies & Catheter Updates (A-Codes)
CMS has phased out generic catheter coding in favor of more specific classifications:
-
- A4295: Intermittent urinary catheter; straight tip, hydrophilic coating.
- A4296: Intermittent urinary catheter; coude (curved) tip, hydrophilic coating.
- A4297: Intermittent urinary catheter; hydrophilic coating, with insertion supplies.
3. New Injectable Drugs & Biosimilars (J & Q Codes)
A significant portion of the 160 new codes are found in the J and Q sections for advanced therapies:
-
- J0013: Esketamine nasal spray, 1 mg (replaces discontinued S0013).
- J1073: Testosterone pellet, implant, 75 mg (replaces discontinued S0189).
- J3387: Injection, elivaldogene autotemcel, per treatment.
- Q5160: Injection, bevacizumab-nwgd (Jobevne), biosimilar, 10 mg.
- Q4411: AmnioMatrixF4X, human cell/tissue cover for wounds.
4. Remote Monitoring & Management Refinements
While foundational codes remain, 2026 adds flexibility for management:
-
- Reduced Management Thresholds: New guidelines allow billing for just 10 minutes of clinical monitoring (e.g., CPT 99470) instead of the previous 20-minute minimum.
- Short-Term Monitoring: New codes (such as CPT 99445) cover 2–15 days of reading per month, offering an alternative to the standard 16-day requirement for device supply.
5. Terminology & Administrative Changes
-
- “Upstream Drivers”: CMS is officially phasing out the term “Social Determinants of Health” (SDoH) in descriptors (e.g., for codes G2076 and G2077) and replacing it with “upstream drivers”.
- Permanent Telehealth: CMS has removed the distinction between “provisional” and “permanent” services on the Medicare telehealth list; all added services are now considered permanent.
HCPCS Level II updates include critical drug code crosswalks and the implementation of new specialty-specific MIPS Value Pathway (MVP) codes.
1. Discontinued J-Code Crosswalks (Effective Jan 1, 2026)
CMS has deleted several long-standing J-codes, often replacing them with more specific permanent codes or standardizing temporary S-codes into the J-series.
| HCPCS | |||
| Discontinued Code | Description | Replacement/Crosswalk Code | |
| S0013 | Esketamine nasal spray | J0013 (Esketamine, 1 mg) | |
| S0189 | Testosterone pellet implant | J1073 (Testosterone pellet, 75 mg) | |
| C9174 | Datopotamab deruxtecan | J9011 (Injection, 1 mg) | |
| C9175 | Treosulfan | J0614 (Injection, 50 mg) | |
| J9098 | Cytarabine liposome | Deleted (No direct crosswalk provided) | |
| J9019 | Erwinaze injection | Deleted (No direct crosswalk provided) | |
| J9020 | Asparaginase, NOS | Deleted (No direct crosswalk provided) | |
| J8650 | Nabilone, oral | Removed from coverage direction | |
2. MIPS Value Pathway (MVP) Codes (M1498–M1503)
CMS introduced a series of M-codes specifically to identify clinicians or groups participating in MIPS Value Pathways. These codes are used for administrative tracking of quality and cost performance within specific clinical specialties.
-
- M1498: Diagnostic Radiology MIPS Value Pathway
- M1499: Interventional Radiology MIPS Value Pathway
- M1500: Neuropsychology MIPS Value Pathway
- M1501: Pathology MIPS Value Pathway
- M1502: Podiatry MIPS Value Pathway
- M1503: Vascular Surgery MIPS Value Pathway
3. Notable Telehealth & Quality M-Codes
-
- M1426, M1431, M1436+: Broad set of codes to identify encounters conducted via telehealth across different clinical scenarios.
- M1482–M1485: New codes for tracking Hepatitis C treatment outcomes, specifically achieving “sustained virological response”.
- M1492–M1497: Specific codes for Falls Risk Management, differentiating between patients who reported a fall and those with a documented plan of care.
4. Administrative Reminders
-
- No Grace Period: Codes discontinued on December 31, 2025, are invalid for 2026 dates of service. Claims using deleted codes for services provided in January 2026 will be denied.
